Pediatrics ( 18 years of age): Such patients should receive a reduced dose of. TORADOL, and their renal status should be closely monitored.
(See Kinetics in Special Populations for use of IV dosing of ketorolac tromethamine in pediatric patients.) dose) to multiple-dose TORADOL. ORAL.
Safety and efficacy have not been established in the pediatric Concomitant administration of TORADOL with low dose ASA increases the risk of
For the pediatric patient, Pediatric: Pain Management. Criteria o Lower dosing of ketorolac (Toradol) should be considered for those
Toradol. Mefenamic Acid Limited information is available regarding the pharmacokinetics of dosing of ketorolac tromethamine in the pediatric population.
Pediatric Color Coded Drug List for pediatric dosages. This formulary is (Toradol). Non-steroidal Anti- inflammatory Drug. NCCEP Protocol: 7-Pain
7.1.2 Breast-feeding. TORADOL IM is contraindicated in breast-feeding women (see 2 CONTRAINDICATIONS). 7.1.3 Pediatrics. Pediatrics ( 18 years
For the pediatric patient, Pediatric: Pain Management. Criteria o Lower dosing of ketorolac (Toradol) should be considered for those
Pediatric Dosing. Acetaminophen. (Tylenol). NCCEP Protocol: 7-Pain Control (Toradol). Non-steroidal Anti- inflammatory Drug. NCCEP Protocol: 7-Pain
Comments